These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Isoniazid hepatotoxicity among drug users: the role of hepatitis C. Fernández-Villar A, Sopeña B, Vázquez R, Ulloa F, Fluiters E, Mosteiro M, Martínez-Vázquez C, Piñeiro L. Clin Infect Dis; 2003 Feb 01; 36(3):293-8. PubMed ID: 12539070 [Abstract] [Full Text] [Related]
3. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. Falagas ME, Voidonikola PT, Angelousi AG. Int J Antimicrob Agents; 2007 Dec 01; 30(6):477-86. PubMed ID: 17913470 [Abstract] [Full Text] [Related]
7. The use of methotrexate in childhood rheumatic diseases. Wallace CA. Arthritis Rheum; 1998 Mar 01; 41(3):381-91. PubMed ID: 9506564 [No Abstract] [Full Text] [Related]
11. [Hepatotoxicity of the tuberculostatic combination INH+RMP+EMB in relation to drug metabolism in the liver]. Musch E, Eichelbaum M, Wang JK, von Sassen W, Ochs HR, Castro-Parra M, Dengler HJ. Med Welt; 1982 Jun 25; 33(25):911-4. PubMed ID: 7109939 [No Abstract] [Full Text] [Related]
17. Should tuberculin skin test be positive to give latent tuberculosis treatment before tumor necrosis factor-alpha inhibitors in selected patients in developing countries? Abud-Mendoza C, Martínez-Martínez MU, DE Jesús Macías-Mendoza J, Magaña-Aquino M. J Rheumatol; 2010 Mar 25; 37(3):672-3; author reply 673. PubMed ID: 20197567 [No Abstract] [Full Text] [Related]
20. Relationship between 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism and methotrexate related toxicity in patients with autoimmune diseases receiving folic acid supplementation. Speletas M, Papadopoulos N, Daiou C, Katodritou E, Pavlitou-Tsiontsi A, Galanopoulou V. Ann Rheum Dis; 2005 Dec 25; 64(12):1791-2. PubMed ID: 16284346 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]